Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness
- 4 November 2012
- journal article
- research article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 35 (2) , 147-154
Abstract
Platelet activation results in the release and upregulation of mediators responsible for immune cell activation and recruitment, suggesting that platelets play an active role in immunity. Animal models and retrospective data have demonstrated benefit of antiplatelet therapy on inflammatory mediator expression and clinical outcomes. This study sought to characterize effects of clopidogrel on the incidence and severity of community-acquired pneumonia (CAP). A retrospective cohort study was conducted of Kentucky Medicaid patients (2001–2005). The exposed cohort consisted of patients receiving at least six consecutive clopidogrel prescriptions; the non-exposed cohort was comprised of patients not prescribed clopidogrel. Primary endpoints included incidence of CAP and inpatient treatment. Secondary severity endpoints included mortality, intensive care unit admission, mechanical ventilation, sepsis, and acute respiratory distress syndrome/acute lung injury. CAP incidence was significantly greater in the exposed cohort (OR 3.39, 95 % CI 3.27–3.51, p < 0.0001) that remained after adjustment (OR 1.48, 95 % CI 1.41–1.55, p < 0.0001). Inpatient treatment was more common in the exposed cohort (OR 1.96, 95 % CI 1.85–2.07, p < 0.0001), but no significant difference remained after adjustment. Trends favoring the exposed cohort were found for the secondary severity endpoints of mechanical ventilation (p = 0.07) and mortality (p = 0.10). Pooled analysis of published studies supports these findings. While clopidogrel use may be associated with increased CAP incidence, clopidogrel does not appear to increase—and may reduce—its severity among inpatients. Because this study was retrospective and could not quantify all variables (e.g., aspirin use), these findings should be explored prospectively.Keywords
This publication has 33 references indexed in Scilit:
- Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome*Critical Care Medicine, 2011
- Neutrophil Transmigration Mediated by the Neutrophil-Specific Antigen CD177 Is Influenced by the Endothelial S536N Dimorphism of Platelet Endothelial Cell Adhesion Molecule-1The Journal of Immunology, 2010
- Lipopolysaccharide Stimulates Platelet Secretion and Potentiates Platelet Aggregation via TLR4/MyD88 and the cGMP-Dependent Protein Kinase PathwayThe Journal of Immunology, 2009
- Effect of Long-Term Clopidogrel Treatment on Platelet Function and Inflammation in Patients Undergoing Coronary Arterial StentingThe American Journal of Cardiology, 2009
- Amicus or AdversaryAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- Anti-platelet drugs and outcome in severe infection: Clinical impact and underlying mechanismsPlatelets, 2009
- Novel uses for anti‐platelet agents as anti‐inflammatory drugsBritish Journal of Pharmacology, 2007
- Clopidogrel inhibits platelet-leukocyte adhesion and plateletdependent leukocyte activationThrombosis and Haemostasis, 2005
- Improved Host Defense against Pneumococcal Pneumonia in Platelet‐Activating Factor Receptor–Deficient MiceThe Journal of Infectious Diseases, 2004
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986